AzTrials
AzTrials

Autism Spectrum DisorderNCT04199533

Iterative Redesign of a Behavioral Skills Training Program for Use in Educational Settings

An observational study of Autism Spectrum Disorder and Disruptive Behavior, run by University of Washington at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study proposes to redesign the RUBI Parent Training program, a low-intensity intervention for youth with autism spectrum disorder and disruptive behavior, for use by school personnel in the classroom. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder, Disruptive Behavior
What is being tested?
RUBI and RUBIES
How many people
40 participants
Where
1 siteUnited States
Study dates
1 Sep 2019to 30 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Elementary school personnel who work with students with autism spectrum disorder

Who may be able to join

  • Elementary school (kindergarten through 5th grade) personnel (i.e. general and special education teachers, school psychologist, paraprofessionals)
  • Works with at least one student with ASD for part of the day

Who cannot join

  • -School personnel who do not have contact with youth with ASD during the work day

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Seattle Public Schools

    Seattle, Washington, 98105

Other trials in United States

About this study

This study proposes to redesign the RUBI Parent Training program, a low-intensity intervention for youth with autism spectrum disorder and disruptive behavior, for use by school personnel in the classroom. Using a mixed-methods approach, 40 school staff members from 20 elementary schools will be recruited to inform current classroom behavior management practices and RUBI redesign needs.

Read the detailed description

Approximately 50% of children with autism spectrum disorder (ASD) exhibit disruptive behaviors such as tantrums, aggression, and noncompliance that significantly impact social, adaptive, and academic functioning. The RUBI program is an evidence-based parent-mediated intervention that improves disruptive behavior in children with ASD. Considering schools serve as the primary intervention setting for children with ASD, and teachers and school staff often struggle to address challenging behavior, there is an opportunity to meaningfully improve care by adapting RUBI for delivery in schools. To address these needs, the Discover, Design/Build, Test (DDBT) framework,which leverages user-centered design and implementation science, will be used to engage 40 end users from 20 elementary schools to inform current classroom behavior management practices and redesign needs for the RUBI curriculum to ensure that the modified curriculum (RUBI in Educational Settings; RUBIES) is useful and useable for school personnel who work with children with ASD. Specific aims include:

Aim 1: Identify the contextual constraints and end users (teachers, school psychologists, behavior technicians, classroom aides) relevant to the management of disruptive behavior in the classroom. Through in-class behavioral observations and interviews, Aim 1 will allow us to understand the values and priorities of the school context and end users directly involved with children with ASD (e.g. resources, work flow, policies).

Aim 2: Identify targets for RUBI redesign. Using in-depth intervention demonstration of RUBI paired with behavioral rehearsal, prospective think-aloud, and structured assessment methods, Aim 2 will allow us to determine which RUBI components should be retained, eliminated, or modified to address the needs of the context and end-users identified in Aim 1.

Aim 3: Iteratively adapt RUBI content and procedures based on identified targets for redesign and continual user testing to improve the hypothesized mechanisms of redesign (usability) and perceptual implementation outcomes (feasibility, acceptability, and appropriateness). Aim 3 will allow us to determine the extent to which redesigned RUBI, or RUBIES, improves usability and implementation outcomes.

Being tested
RUBI, RUBIES
Medical subject headings
Autism Spectrum Disorder, Problem Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RUBIBehavioural

    Parent-mediated behavioral program targeting disruptive behavior utilizing principle of applied behavior analysis

  • RUBIESBehavioural

    School-staff mediated behavioral program targeting disruptive behavior utilizing principle of applied behavior analysis

Study groups in NCT04199533
Study groupRoleWhat they receive
Classroom ObservationThe investigators will use day-long observational and interview procedures with eight staff from four schools. The classroom observation will focus on documenting episodes of classroom disruptive behavior, including antecedents and consequences to the behaviors. The interview will involve discussing with staff decision-making processes and current needs around classroom behavioral management.
RUBI RedesignTwo separate demonstration studies comprising 6 staff members each will focus on informing adaptation or pruning needs related to RUBI content and structure to ensure the redesigned curriculum (RUBIES) is contextually appropriate for schools.
Receives: Behavioral: RUBI
RUBIES Collaborative DesignEight staff from 4 schools will attend one of four 2-hour in-person feedback sessions to support collaborative feedback around RUBI redesign, including feasibility and appropriateness and methods supporting implementation.
Receives: Behavioral: RUBIES
RUBIES RedesignTwo separate demonstration studies comprising 6 staff members each will focus on informing final RUBIES adaptation or pruning needs.
Receives: Behavioral: RUBIES

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of Intervention Measure (AIM): 5-point scale

    The 4-item AIM assesses participants' acceptability of RUBI(ES). Raters score items on a 5-point scale ranging from (1) "Completely Disagree" to (5) "Completely Agree". Internal consistency (α = .89) and test-retest reliability were good (α = .83).

    Measured: Completed by participants during the 4-hour RUBI Redesign meeting (Aim 1)

  2. Acceptability of Intervention Measure (AIM): 5-point scale

    The 4-item AIM assesses participants' acceptability of RUBI(ES). Raters score items on a 5-point scale ranging from (1) "Completely Disagree" to (5) "Completely Agree". Internal consistency (α = .89) and test-retest reliability were good (α = .83).

    Measured: Completed by participants during the 4-hour RUBIES Redesign meeting (Aim 3)

  3. Intervention Appropriateness Measure (IAM): 5-point scale

    The 4-item IAM assesses the appropriateness of RUBI(ES). Raters score each item on a 5-point scale ranging from (1) "Completely Disagree" to (5) "Completely Agree". Internal consistency (α = .87) and test-retest reliability were good (α = .87).

    Measured: Completed by participants during the 4-hour RUBI Redesign meeting (Aim 1)

  4. Intervention Appropriateness Measure (IAM): 5-point scale

    The 4-item IAM assesses the appropriateness of RUBI(ES). Raters score each item on a 5-point scale ranging from (1) "Completely Disagree" to (5) "Completely Agree". Internal consistency (α = .87) and test-retest reliability were good (α = .87).

    Measured: Completed by participants during the 4-hour RUBIES Redesign meeting (Aim 3)

  5. Feasibility of Intervention Measure (FIM): 5-point scale

    The 4-item FIM assesses the feasibility of RUBI(ES). Raters score each item on a 5-point scale ranging from (1) "Completely Disagree" to (5) "Completely Agree". Internal consistency (α = .89) and test-retest reliability were good (α = .88).

    Measured: Completed by participants during the 4-hour RUBI Redesign meeting (Aim 1)

  6. Feasibility of Intervention Measure (FIM): 5-point scale

    The 4-item FIM assesses the feasibility of RUBI(ES). Raters score each item on a 5-point scale ranging from (1) "Completely Disagree" to (5) "Completely Agree". Internal consistency (α = .89) and test-retest reliability were good (α = .88).

    Measured: Completed by participants during the 4-hour RUBIES Redesign meeting (Aim 3)

Secondary outcomes (2)
  1. Intervention Usability Scale (IUS)

    The 10-item IUS is adapted from the System Usability Scale and assesses intervention usability on a 5-point scale ranging from (1) "Strongly Disagree" to (5) "Strongly Agree." A score ≥70 on the IUS demonstrates "good" or better usability.

    Measured: Completed by participants during the 4-hour RUBI Redesign meeting (Aim 1)

  2. Intervention Usability Scale (IUS)

    The 10-item IUS is adapted from the System Usability Scale and assesses intervention usability on a 5-point scale ranging from (1) "Strongly Disagree" to (5) "Strongly Agree." A score ≥70 on the IUS demonstrates "good" or better usability.

    Measured: Completed by participants during the 4-hour RUBIES Redesign meeting (Aim 3)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2019
  2. Study start1 Sep 2019
  3. Primary completion30 Jun 2021
  4. Study completion30 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04199533
Sponsor's protocol ID
SCH-STUDY00001890
Other IDs
1P50MH115837
Status last verified
May 2022
First submitted
9 Oct 2019
Last updated
20 May 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder and Disruptive Behavior, run by University of Washington at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of Intervention Measure (AIM): 5-point scale (time frame: Completed by participants during the 4-hour RUBI Redesign meeting (Aim 1)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04199533 | AzTrials